Lyme Disease Completed Phase 3 Trials for Ceftriaxone (DB01212)

Also known as: Lyme disease / Lymes disease / Borrelia burgdorferi infection / Lyme borreliosis / Lyme's disease / Lyme disease, unspecified

IndicationStatusPhase
DBCOND0027964 (Lyme Disease)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000938A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme DiseaseTreatment
NCT00001101A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme DiseaseTreatment